Johannes De Haard

5 Patents

• US125655382026

  Fcrn/antigen-binding Molecules and Methods of Use

  Argenx BV

  0 cites
• US123446782025

  Fcrn/hsa Binding Molecules and Methods of Use

  Argenx BV

  0 cites
• US122408752025

  Use of FCRN Antagonists for Treatment of Generalized Myasthenia Gravis

  Argenx BV

  0 cites
• US120604132024

  Method of Preparing Ph-dependent Antibodies

  Argenx BV

  0 cites
• US117124682023

  CD70 Combination Therapy

  University Of Bern

  0 cites